Levothyroxine Sodium Tablet
Product Images NDC 71335-2039

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Levothyroxine Sodium (NDC 71335-2039). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Levothyroixe Molecule (Levothyroxine Molecule)

Levothyroixe Molecule (Levothyroxine Molecule)
Chemical structure of levothyroxine sodium showing iodine-substituted aromatic rings and functional groups including hydroxyl, amine, carboxylate, and associated sodium and water of hydration.*
FDA Label Image

Label (Lbl713352039)

Label (Lbl713352039)
Levothyroxine Sodium Tablets USP, 75 mcg (0.075 mg), oral tablets, repackaged by Bryant Ranch Prepack, Inc. and manufactured by Neolpharma, Inc. The label shows an NDC number 71335-2039-1 and mentions a package size of 30 tablets. Storage instructions and warnings about keeping out of reach of children and using a child-resistant container are included.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.